New vaccines for immunisation schedule: Boostrix-IPV and Infanrix-IPV+Hib

From 1st July 2014, Boostrix-IPV replaces Repevax for immunisation of pregnant women and Infanrix-IPV+Hib is available as an alternative to Pediacel for childhood immunisation.

Both Boostrix-IPV and Infanrix-IPV+Hib are available to order via the ImmForm website.
Both Boostrix-IPV and Infanrix-IPV+Hib are available to order via the ImmForm website.

Boostrix-IPV replaces Repevax

The recommended vaccine offered to pregnant women (28 to 38 weeks) to protect their newborns from pertussis is changing from Repevax to Boostrix-IPV (containing diphtheria, tetanus, acellular pertussis and inactivated poliovirus).

Repevax remains available to order for the pre-school booster programme, alongside Infanrix-IPV.

Infanrix-IPV+Hib alternative to Pediacel

Additionally, Infanrix-IPV+Hib has been introduced as an alternative infant vaccine for the primary immunisation programme, alongside Pediacel. The two vaccines are interchangeable; however, where possible the same brand should be used for all 3 doses of the primary vaccine course.

Both vaccines protect against diphtheria, tetanus, whooping cough, polio and Hib. Infanrix-IPV+Hib contains 3 pertussis components, whilst Pediacel has 5 components but with a slightly lower antigen content. Post-licensing surveillance has not shown any differences between the vaccines in effectiveness or disease control. Pediacel is supplied as a pre-filled syringe whereas Infanrix-IPV+Hib requires reconstitution before administration. 

View Boostrix-IPV record

View Infanrix-IPV+Hib record

Further information: GlaxoSmithKline

View updated intelog summary of routine childhood immunisation schedule

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in